American Society of Hematology, 2025 (ASH) 7 - 9 December 2025

From efficacy to experience: 52-week patient-reported outcomes with Mim8 in adolescents and adults with Hemophilia A with or without inhibitors (FRONTIER2)

Authors :

Cedric Hermans¹, Sanjay Ahuja², Hazza Alzahrani³, Cihan Ay⁴, Peter Kampmann⁵, Samya Obaji⁶, Sophie Susen⁷, Ciprian Tomuleasa⁸, Lize van Vulpen⁹, Amalie Rhode Høgh Nielsen¹⁰, Ilgiz Rakhmatullin¹⁰, Carmen Escuriola-Ettingshausen¹¹

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Haemophilia

Congress oral presentation

Mim8

Search Science Hub

Are you a healthcare professional?

From efficacy to experience: 52-week patient-reported outcomes with Mim8 in adolescents and adults with Hemophilia A with or without inhibitors (FRONTIER2)